CareLit · DOI-Nachweis · Pneumologie
Bosentan in the Treatment of Pulmonary Arterial Hypertension in Adults with Congenital Heart Defects: Preliminary Experience of a Multicenter Cooperation Project
DOI 10.1055/s-2005-864363
Bibliografische Angaben
Nachweis in CareLit
Autor:innenI Schulze-Neick, N Gilbert, K Lunze, R Ewert, C Witt, E Grünig, H Olschewski, MM Borst, P Lange, M Höper
ZeitschriftPneumologie
Ausgabe03/2005
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Bosentan is effective in the treatment of primary pulmonary arterial hypertension (PAH). As yet there are no published data concerning its use in adult PAH patients with congenital heart defects. Methods: Thirty-four patients (age 45±15 years; 23 pts with Eisenmenger syndrome) at 6 specialized centers were treated with a bosentan dose of 62,5–250mg/d. Before and after 16,4±5,7 months of therapy, clinic…
Zitieren
Zitierempfehlung
I Schulze-Neick, N Gilbert, K Lunze, R Ewert, C Witt, E Grünig, H Olschewski, MM Borst, P Lange, M Höper (2005) Bosentan in the Treatment of Pulmonary Arterial Hypertension in Adults with Congenital Heart Defects: Preliminary Experience of a Multicenter Cooperation Project. Pneumologie (03). https://doi.org/10.1055/s-2005-864363
Mit CareLit weiterarbeiten